Home » Topics » BioWorld Science

BioWorld Science
RSS

Dana-Farber Cancer Institute presents new EGFR and/or HER2 inhibitors

March 28, 2019

Angion Biomedica identifies Rho-associated protein kinase 1/2 inhibitors

March 28, 2019

New monoglyceride lipase inhibitors described by Abide Therapeutics

March 28, 2019

Bristol-Myers Squibb discovers STING agonists

March 28, 2019

Positive phase I/II mid-study results reported for ApoGraft

March 28, 2019

Urovant Sciences launches international phase III COURAGE study of vibegron

March 28, 2019

Kalyra Pharmaceuticals starts phase I study of KP-1199

March 28, 2019

Daiichi Sankyo initiates dosing in phase III AMELA study of mirogabalin

March 28, 2019

Probiotics for treating autism prepared at Beijing Jinfeng Labs Technology

March 28, 2019

Targeting intracellular PD-L1 strengthens checkpoint blockade

March 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...